Literature DB >> 34211066

Prevalence of UL97 gene mutations and polymorphisms in cytomegalovirus infection in the colon associated with or without ulcerative colitis.

Satoshi Tamura1,2, Satoshi Osawa3, Natsuki Ishida2, Takahiro Miyazu2, Shinya Tani2, Mihoko Yamade2, Moriya Iwaizumi4, Yasushi Hamaya2, Isao Kosugi5, Takahisa Furuta6, Ken Sugimoto2.   

Abstract

Cytomegalovirus (CMV) reactivation in the colon is common in patients with severe ulcerative colitis (UC). Ganciclovir (GCV) resistance conferring CMV UL97 gene mutations have been reported in recent years. However, the prevalence of UL97 gene mutations in GCV-naive CMV infection in the colon remains unknown. We investigated the prevalence of CMV UL97 gene mutations in patients with colonic CMV infection associated with or without UC. Twenty-two GCV-naive patients with colonic CMV infection, 15 with UC and 7 with other diseases, were enrolled. Frozen biopsy samples or formalin-fixed paraffin-embedded samples were used for nested polymerase chain reaction (PCR) amplification of the UL97 gene. Sanger DNA sequencing was performed. In comparison with AD169 reference strain, natural polymorphisms were frequently detected in codons N68D (100%), I244V (100%), and D605E (86.4%). Seven polymorphisms were detected infrequently (< 10%) outside the kinase domain. However, no known GCV resistance mutations were found. There seemed to be no difference between the ratio of polymorphisms in patients with and without UC. In conclusions, we did not detect UL97 gene mutations associated with GCV resistance in GCV-naive patients with or without UC. Consistent with previous reports, D605E polymorphism may be used as a genetic marker for CMV in East Asian countries.

Entities:  

Year:  2021        PMID: 34211066     DOI: 10.1038/s41598-021-93168-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  39 in total

Review 1.  Strategies for managing cytomegalovirus in transplant recipients.

Authors:  Raymund R Razonable
Journal:  Expert Opin Pharmacother       Date:  2010-08       Impact factor: 3.889

2.  Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis.

Authors:  Sylvie Pillet; Camille Jarlot; Mathilde Courault; Emilie Del Tedesco; Renaud Chardon; Pierre Saint-Sardos; Emilie Presles; Jean-Marc Phelip; Philippe Berthelot; Bruno Pozzetto; Xavier Roblin
Journal:  Inflamm Bowel Dis       Date:  2015-07       Impact factor: 5.325

3.  Updates on antiviral drugs for cytomegalovirus prevention and treatment.

Authors:  Camille N Kotton
Journal:  Curr Opin Organ Transplant       Date:  2019-08       Impact factor: 2.640

Review 4.  Ulcerative Colitis and Cytomegalovirus Infection: From A to Z.

Authors:  Fadi H Mourad; Jana G Hashash; Viraj C Kariyawasam; Rupert W Leong
Journal:  J Crohns Colitis       Date:  2020-09-07       Impact factor: 9.071

Review 5.  Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.

Authors:  Sylvie Pillet; Bruno Pozzetto; Xavier Roblin
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 6.  Antiviral drug resistance of human cytomegalovirus.

Authors:  Nell S Lurain; Sunwen Chou
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis.

Authors:  Xavier Roblin; Sylvie Pillet; Abderrahim Oussalah; Philippe Berthelot; Emilie Del Tedesco; Jean-Marc Phelip; Marie-Laure Chambonnière; Olivier Garraud; Laurent Peyrin-Biroulet; Bruno Pozzetto
Journal:  Am J Gastroenterol       Date:  2011-07-26       Impact factor: 10.864

8.  Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis.

Authors:  Ariadna Clos-Parals; Paula Rodríguez-Martínez; Fiorella Cañete; Míriam Mañosa; Alejandra Ruiz-Cerulla; Mª José Paúles; Jordina Llaó; Jordi Gordillo; Caterina Fumagalli; Esther Garcia-Planella; Isabel Ojanguren; Eduard Cabré; Jordi Guardiola; Eugeni Domènech
Journal:  J Crohns Colitis       Date:  2019-03-26       Impact factor: 9.071

9.  Cytomegalovirus infections in solid organ transplantation: a review.

Authors:  Poornima Ramanan; Raymund R Razonable
Journal:  Infect Chemother       Date:  2013-09-27

Review 10.  Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review.

Authors:  Petros I Rafailidis; Eleni G Mourtzoukou; Ioannis C Varbobitis; Matthew E Falagas
Journal:  Virol J       Date:  2008-03-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.